Viewing Study NCT07493668


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-04-10 @ 2:21 PM
Study NCT ID: NCT07493668
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-25
First Post: 2026-03-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fostrox Plus Lenvatinib vs Lenvatinib in Advanced Hepatocellular Carcinoma After First-line Immunotherapy
Sponsor: CHA University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma (HCC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HCC View